Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice

Isoliquiritigenin (ISL) exhibits antioxidation and anti-inflammation activity. We sought to investigate the effects and mechanism of ISL on the development of atherosclerotic lesions in apolipoprotein E-deficient (apoE(−/−)) mice. Firstly, we determined that ISL reduced the mRNA levels of inflammato...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Fen, Gesang, Quzhen, Cao, Jia, Qian, Mei, Ma, Li, Wu, Dongfang, Yu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133927/
https://www.ncbi.nlm.nih.gov/pubmed/27869741
http://dx.doi.org/10.3390/ijms17111932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133927/
https://www.ncbi.nlm.nih.gov/pubmed/27869741
http://dx.doi.org/10.3390/ijms17111932

Ejemplares similares